Paula H Cholmondeley insider trades: Lexeo Therapeutics (LXEO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Paula reports to the SEC
and 3 more companies
Open-market buys and sales
47 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | LXEO | ↑ Buy | 15,000 | $6.99 | $105K | Direct | Nov 26, 2024 (1d) |
| Nov 4, 2022 | TEX | ↓ Sell | 20,000 | $41.22 | $824K | Direct | Nov 8, 2022 (4d) |
| Sep 30, 2020 | TEX | ↓ Sell | 2,853 | $19.61 | $56K | Direct | Oct 1, 2020 (1d) |
| Sep 30, 2020 | TEX | ↑ Buy | 2,853 | $19.47 | $56K | Direct | Oct 1, 2020 (1d) |
| Mar 19, 2020 | TEX | ↑ Buy | 20,000 | $12.64 | $253K | Direct | Mar 20, 2020 (1d) |
| Jun 7, 2019 | TEX | ↓ Sell | 2,653 | $28.24 | $75K | Direct | Jun 11, 2019 (4d) |
| Jun 7, 2019 | TEX | ↑ Buy | 2,653 | $28.23 | $75K | Direct | Jun 11, 2019 (4d) |
| Jun 22, 2018 | TEX | ↓ Sell | 16,214 | $41.29 | $669K | Direct | Jun 26, 2018 (4d) |
| May 3, 2017 | KS | ↑ Buy | 972 | $20.20 | $20K | Direct | May 3, 2017 (0d) |
| Apr 20, 2017 | OZRK | ↑ Buy | 1,214 | $49.36 | $60K | Direct | Apr 21, 2017 (1d) |
| May 20, 2016 | OZRK | ↑ Buy | 1,348 | $37.34 | $50K | Direct | May 24, 2016 (4d) |
| Mar 10, 2016 | TEX | ↑ Buy | 3,038 | $21.32 | $65K | Direct | Mar 11, 2016 (1d) |
| Mar 10, 2016 | TEX | ↓ Sell | 3,038 | $21.30 | $65K | Direct | Mar 11, 2016 (1d) |
| May 21, 2015 | TEX | ↑ Buy | 2,620 | $28.56 | $75K | Direct | May 26, 2015 (5d) |
| Aug 29, 2013 | TEX | ↑ Buy | 4,019 | $29.90 | $120K | Direct | Aug 30, 2013 (1d) |
| Aug 29, 2013 | TEX | ↓ Sell | 2,044 | $29.95 | $61K | Direct | Aug 30, 2013 (1d) |
| Mar 12, 2013 | XRAY | ↓ Sell | 9,000 | $42.70 | $384K | Direct | Mar 13, 2013 (1d) |
| Mar 1, 2013 | XRAY | ↓ Sell | 9,000 | $41.05 | $369K | Direct | Mar 5, 2013 (4d) |
| Feb 28, 2013 | TEX | ↑ Buy | 3,539 | $33.10 | $117K | Direct | Mar 1, 2013 (1d) |
| Jun 18, 2012 | TEX | ↑ Buy | 5,469 | $18.23 | $100K | Direct | Jun 20, 2012 (2d) |
| May 14, 2012 | AIN | ↓ Sell | 2,600 | $19.83 | $52K | Direct | May 16, 2012 (2d) |
| May 14, 2012 | AIN | ↑ Buy | 2,600 | $19.83 | $52K | by 401(k) | May 16, 2012 (2d) |
| Feb 25, 2011 | AIN | ↑ Buy | 5,380 | $22.95 | $123K | Direct | Feb 28, 2011 (3d) |
| Feb 25, 2011 | AIN | ↑ Buy | 635 | $23.12 | $15K | by 401(k) | Feb 28, 2011 (3d) |
| Feb 11, 2011 | XRAY | ↓ Sell | 18,000 | $36.48 | $657K | Direct | Feb 15, 2011 (4d) |
| May 17, 2010 | AIN | ↓ Sell | 4,900 | $23.92 | $117K | Direct | May 19, 2010 (2d) |
| Nov 24, 2009 | ULBI | ↓ Sell | 2,529 | $4.00 | $10K | Indirect | Nov 25, 2009 (1d) |
| Nov 2, 2009 | ULBI | ↑ Buy | 1,563 | $3.77 | $6K | Direct | Nov 2, 2009 (0d) |
| Nov 2, 2009 | ULBI | ↓ Sell | 1,553 | $3.73 | $6K | Direct | Nov 2, 2009 (0d) |
| Aug 3, 2009 | ULBI | ↑ Buy | 2,877 | $6.71 | $19K | Direct | Aug 4, 2009 (1d) |
| Aug 3, 2009 | ULBI | ↓ Sell | 1,402 | $6.49 | $9K | Direct | Aug 4, 2009 (1d) |
| May 12, 2009 | ULBI | ↑ Buy | 4,728 | $7.38 | $35K | Direct | May 14, 2009 (2d) |
| May 7, 2009 | TEX | ↑ Buy | 175 | $15.38 | $3K | Direct | May 8, 2009 (1d) |
| May 4, 2009 | TEX | ↓ Sell | 175 | $15.37 | $3K | Direct | May 6, 2009 (2d) |
| May 4, 2009 | ULBI | ↓ Sell | 4,728 | $7.38 | $35K | Direct | May 5, 2009 (1d) |
| Nov 5, 2008 | TEX | ↑ Buy | 1,260 | $16.57 | $21K | Direct | Nov 6, 2008 (1d) |
| Nov 5, 2008 | (XRAY) | ↑ Buy | 360 | $29.87 | $11K | Direct | Nov 6, 2008 (1d) |
| Sep 8, 2008 | TEX | ↑ Buy | 262 | $37.54 | $10K | Direct | Sep 9, 2008 (1d) |
| Dec 28, 2007 | ULBI | ↓ Sell | 4,000 | $19.55 | $78K | Direct | Jan 2, 2008 (5d) |
| Dec 28, 2007 | ULBI | ↑ Buy | 3,000 | $20.03 | $60K | Direct | Jan 2, 2008 (5d) |
| Nov 28, 2007 | AIN | ↑ Buy | 1,417 | $37.92 | $54K | 401(k) | Nov 29, 2007 (1d) |
| Nov 28, 2007 | AIN | ↓ Sell | 1,417 | $37.26 | $53K | Direct | Nov 29, 2007 (1d) |
| Aug 7, 2006 | MTX | ↑ Buy | 200 | $50.49 | $10K | Direct | Aug 8, 2006 (1d) |
| Jun 16, 2006 | ULBI | ↑ Buy | 240 | $8.54 | $2K | Direct | Jun 19, 2006 (3d) |
| Jun 9, 2006 | ULBI | ↑ Buy | 830 | $10.01 | $8K | Direct | Jun 12, 2006 (3d) |
| Jan 4, 2006 | TEX | ↑ Buy | 1,027 | $60.84 | $62K | Direct | Jan 4, 2006 (0d) |
| Nov 2, 2005 | MTX | ↑ Buy | 200 | $53.25 | $11K | Direct | Nov 3, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LXEO insiders
Open-market trades in the last 12 months
About Paula H Cholmondeley's insider trades
Paula H Cholmondeley is an insider at Lexeo Therapeutics (LXEO). Since Nov 2, 2005, Paula has reported 29 open-market purchases worth $1.6M and 18 sales worth $3.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (183 filings), option exercises (5 filings), other transactions (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LXEO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.